which semaglutide is fda approved Approves Oral Semaglutide: First GLP-1 Weight Loss Pill Novo Nordisk secures FDA approval

In the first week, you can expect: Modest weight loss of 2-5 lbs as the medication begins to take effect Appetite suppression as one of the first noticeable effects Potential GI side effects like nausea as your body adjusts With semaglutide, the weight does not seem to come off rapidly or easily at first

If you experience persistent nausea, the dose escalation protocol matters enormously

However, various clinical studies have demonstrated that people using Semaglutide GLP-1 achieve significant weight loss within a relatively short period of time

Who May Not Be A Candidate (Medical Exclusions) While semaglutide is a powerful tool, it is not safe or suitable for everyone

2.3 Pharmacodynamics The effects of oral semaglutide on fasting and post-prandial glucose and on lipid metabolism were investigated in a double-blinded crossover trial of 15 individuals with T2D

The rationale is that smaller, more frequent doses may produce smoother drug levels with fewer peak-related side effects